newsfilter
← Latest News
GlobeNewswire·

Entera Bio Announces Pricing of Oversubscribed $275 Million Private Placement

The offering is led by existing investor BVF Partners L.P. Expected gross proceeds are anticipated to extend the Company's cash runway into 2030 and fully support Phase 3 registrational studies for EB613, the first